Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 773 of 6351
-
Judo's next edge: training in thin air with reverse pedaling
Knowledge-focused Stopped earlyThe main objective of this study is to evaluate the effects of an innovative training program on key factors affecting judo performance. This program includes high-intensity conventional cycling sessions in hypoxic conditions (simulated altitude), with or without eccentric cyclin…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
New drug combo aims to shrink advanced cervical cancer
Disease control OngoingThis research is being done to determine how effective dostarlimab in combination with cobolimab is in metastatic or recurrent cervical cancer.
Phase 2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New Gene-Modified immune cells take on tough lymphoma
Disease control Recruiting nowThe goal of this clinical trial is to to evaluate the safety and efficacy of TranspoCART19 in patients with relapsed/refractory B-lymphoma. The main questions it aims to answer are: Maximum tolerated dose (MTD) Response rates Participants will be treated with the investigational…
Phase 1/2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Leukemia patients who failed stopping meds may get another shot at drug-free remission
Disease control Recruiting nowTo evaluate the efficacy of asciminib adding on tyrosine-kinase inhibitors (TKI) to achieve treatment-free remission (TFR) in chronic myeloid leukemia (CML) patients in chronic phase who failed prior cessation study of TKI
Phase 2 • Sponsor: Korean Society of Hematology • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThe purpose of the study is to evaluate how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deucravacitinib.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a family workshop curb sexual risks in latina teens?
Prevention CompletedFloreciendo is a sexual and reproductive health workshop for Latina teens (ages 14-18 years) and their female caregivers (e.g., mothers, sisters, grandmothers). This study involves conducting a pilot optimization trial of Floreciendo using the multiphase optimization strategy (MO…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
Ancient herbs face off against metformin in diabetes trial
Disease control OngoingThe goal of this clinical trial to learn the clinical efficacy and safety of standardized polyherbal capsule weighing around 500 mg, containing Syzygium cumini, Momordica charantia, Wrightia tinctoria, and Gymnema sylvestre in equal proportions for controlling Diabetic hyperglyce…
Phase 3 • Sponsor: Hamdard University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI brain scans may forecast learning challenges in children who had birth oxygen deprivation
Knowledge-focused By invitation onlyNeonatal HIE increases the risk for cognitive impairments in childhood. Neonatal MRI brain scans are a strong predictor for outcome, however a normal scan has only a 35% sensitivity and 85% specificity for a normal outcome. This may be explained by variability in the brain's deve…
Sponsor: University College Cork • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Can a peptide shield kidneys during bypass surgery? new trial aims to find out
Disease control Recruiting nowTo evaluate the percentage of subjects with AKI within 7 days following on-pump cardiac surgery defined by the KDIGO (Kidney Disease: Improving Global Outcomes) criteria: 1. Increase in baseline (pre-surgery) serum creatinine (SCr) by ≥26.5 μmol/L (≥0.3 mg/dL) within 7 days; OR …
Phase 2 • Sponsor: Arch Biopartners Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug aims to keep myeloma in check after CAR-T
Disease control Recruiting nowThis research is being done to see if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory multiple myeloma.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis is a phase 2 study of gemcitabine, cisplatin, zimberelimab (AB122) and quemliclustat (AB680) in subjects with untreated advanced biliary tract cancers (BTC). The study will include a safety run-in involving 6 study participants. The goal of the safety run-in is to screen for…
Phase 2 • Sponsor: Nataliya Uboha • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Timing eye injections: could 3, 7, or 14 days before surgery matter?
Disease control CompletedThe goal of this prospective randomized controlled study is to compare the therapeutic effect of injecting anti-VEGF drugs before surgery for patients with proliferative diabetic retinopathy at different time points. At present, studies have confirmed that anti-VEGF drugs are eff…
Sponsor: Jie Li • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
A simpler heart scan could catch cancer treatment side effects
Diagnosis Recruiting nowTRUST-ACE will compare a simplified echocardiographic protocol focusing on ventricular function with the guideline recommended comprehensive echocardiographic examination using a randomised design in follow-up of breast-cancer patients with respect to identification of cancer tre…
Sponsor: Norwegian University of Science and Technology • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New radioactive drug targets Hard-to-Treat prostate cancer
Disease control Recruiting nowResearchers are looking for a better way to treat participants who have metastatic castration-resistant prostate cancer (mCRPC). mCRPC is a cancer of the prostate (male reproductive gland found below the bladder) that has spread to other parts of the body. This type of prostate …
Phase 1 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New malaria pill shows promise in large trial
Disease control CompletedThis study aims to confirm the efficacy, safety and tolerability of KLU156, a fixed dose combination of ganaplacide (KAF156) and a solid dispersion formulation of lumefantrine (lumefantrine-SDF), when administered once daily for three days in adults and children ≥ 10 kg of body w…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immune reset: CAR-T therapy takes on lupus
Disease control PausedThis is an open, Phase I, investigator-initiated study (IIT) to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-04 in patients with moderate or severe active SLE. This study will explore the safety of escalating doses of RD06-04 by pre…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug combo aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowN3 classification, rENE positivity is a high-risk type of locally advanced nasopharyngeal carcinoma. EBV DNA remaining at detectable levels after induction chemotherapy is also a characteristic of high-risk nasopharyngeal carcinoma. Based on the available evidence, patients with …
Phase 3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Which knee implant feels more natural? a trial puts two designs to the test
Disease control OngoingBackground and Rationale: Conventional mechanical implantation of total knee arthroplasty (TKA) aims to establish a lower-limb mechanical axis of 180°. Computer-assisted personalized implantation aims to restore a pre-arthritic alignment while respecting the soft-tissue envelope…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a monthly shot slow stiff heart valves? new trial aims to find out.
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) administered subcutaneously once monthly compared to placebo in slowing the progression of calcific aortic valve stenosis.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Blood test may spare throat cancer patients from radiation side effects
Knowledge-focused Recruiting nowPatients with human papillomavirus (HPV)-related oropharyngeal cancer generally have favorable outcomes and how well they do depends on the specific details about the patient and their cancer. How well they do isn't as related to the kinds of treatment they get. However, there ar…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC